With many new recalls of foods containing peanut butter or peanut paste, the Food and Drug Administration is now recommending that consumers avoid all commercially prepared foods made with peanut butter or eating peanut butter served in institutional settings.
Current recalls, listed on the FDA website, include a variety of cookies, candies, sandwich crackers, ice cream, and frozen pastry with many different labels. Read the rest of this entry »
The Kellogg Company has put a hold on shipping its sandwich crackers with peanut butter. It is removing them from retail store shelves and asks consumers not to eat them until further notice that their safety is assured.
Products affected include Austin® and Keebler® branded Toasted Peanut Butter Sandwich Crackers, Peanut Butter and Jelly Sandwich Crackers, Cheese and Peanut Butter Sandwich Crackers, and Peanut Butter-Chocolate Sandwich Crackers Read the rest of this entry »
The Food and Drug Administration and the King Nut Companies have announced a recall of King Nut Peanut Butter after Salmonella was found in an open five pound tub of peanut butter. King Nut is also recalling Parnell’s Pride peanut butter, which is manufactured by the same company that makes King Nut.
King Nut Companies distribute both the King Nut and Parnell’s Pride brands of peanut butter for institutional use. However, they are both manufactured by the Peanut Corporation of America. Parnell’s Pride is also distributed by other companies.
King Nut does not sell peanut butter directly to consumers, but distributes it to food service accounts only. None of the other King Nut products are affected by the recall.
Martin Kanin, President and CEO of King Nut Companies said,
We are very sorry this happened. We are taking immediate and voluntary action because the health and safety of those who use our products is always our highest priority.
On December 23, 2008 Ethex Corporation recalled one lot of 2 mg hydromorphone tablets because it may contain oversized pills.
Hydromorphone is used to manage pain. Too high a dose could cause difficulty breathing, excessive sedation, or low blood pressure. Patients taking hydromorphone who experience these adverse effects should contact their doctor immediately. If the patient cannot breathe or doesn’t respond, call 911.
The lot recalled is #90219. The round tablets are blue with a script “E” on one side and a “2″ on the other side. Hydromorphone is also marketed by Abbott with the brandname Dilaudid® Read the rest of this entry »
The Food and Drug Administration’s (FDA) Oncology Drug Advisory Committee (ODAC) is meeting today to discuss whether the labels for Erbitux (cetuximab) and Vectibix (panitumumab) should include a mention of KRAS testing. The discussion at the meeting will have implications for future development of companion diagnostics. C3 President Carlea Bauman will be testifying during the public comment section: Read the rest of this entry »
